Table 2.
The testing hepatitis C care cascade by specialty for patients with hepatitis C-coded episode, 2018–2021.
| Specialty | Admissions (n = 1214) | Unique Patients (n = 628) | Antibody Testing, n (% of Patients) | Antibody Positive, n (% of Total Antibody Testing) | RNA Testing, n (% of Antibody Positive) | RNA Positive, n (% of Total RNA Testing) |
|---|---|---|---|---|---|---|
| Hepatitis specialist | 188 (15.5%) | 108 (57.4%) | 27 (25%) | 45 (90%) | 21 (46.7%) | 23 (65.7%) |
| Emergency | 101 (8.3%) | 81 (80.2%) | 13 (16%) | 26 (92.9%) | 15 (57.7%) | 11 (64.7%) |
| Surgical | 231 (19%) | 187 (81%) | 37 (19.8%) | 52 (89.7%) | 30 (57.7%) | 27 (67.5%) |
| General Medicine | 248 (20.4%) | 154 (62.1%) | 68 (44.2%) | 98 (96.1%) | 55 (56.1%) | 37 (56.9%) |
| Mental Health | 77 (6.3%) | 60 (77.9%) | 21 (35%) | 35 (89.7%) | 20 (57.1%) | 18 (69.2%) |
| Obstetrics and Gynecology | 49 (4%) | 34 (69.4%) | 7 (20.6%) | 18 (90%) | 12 (66.7%) | 10 (76.9%) |
| Other specialty medicine | 320 (26.4%) | 133 (41.6%) | 27 (20.3%) | 42 (82.4%) | 21 (50%) | 19 (63.3%) |
| Total | 1214 | 628 | 239 (38%) | 229 (95.8%) | 151 (65.9%) | 90 (59.6%) |